Despite having an allogeneic cell therapy prospect that’s ready for late-stage testing in lymphoma, Caribou couldn’t secure ...
A Dutch court barred Merck from selling subcutaneous Keytruda in several European countries. Elsewhere, an Insmed executive ...
Cerevance, a private, Boston-based biotechnology company, said Wednesday that its most advanced experimental drug succeeded in a late-stage clinical trial focused on Parkinson’s disease. Cerevance’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results